Management of Acne: A Report from a Global Alliance to Improve Outcomes in Acne
Key consensus recommendations:
Acne pathophysiology should influence treatment, which should target as many factors as possible.
Retinoids
Most patients with acne benefit from a retinoid – with a topical agent as part of conventional therapy, or oral isotretinoin for treatment-resistant cases.
Topical retinoids have multiple anti-acne actions, and should be primary treatment for most forms of acne vulgaris.
Use early for best results.
Should be applied to the entire affected area.
Combine with antimicrobial therapy when inflammatory lesions are present.
Essential part of maintenance therapy.
Antimicrobials plus topical retinoid therapy
Antimicrobial therapy plus topical retinoid therapy is significantly better than antimicrobials alone.
Combination therapy allows targeting of different pathophysiologic factors.
Topical retinoid therapy is likely to enhance penetration of antimicrobial agents.
Add topical retinoids early—at the onset of therapy—for greatest and fastest results.
Maintain success by continuing with topical retinoid.
Combination therapy
Should be used when inflammatory lesions are present.
Speeds clearing and provides greater resolution of both inflammatory lesions and comedones
Topical retinoid should be started at the initiation of antimicrobial therapy
Antibiotic should be discontinued when inflammatory lesions resolve adequately.
If this is not possible, then switch to a combination agent with benzoyl peroxide plus an antibiotic.
Continue use of topical retinoid to maintain remission of new acne lesions when antibiotic therapy is discontinued.
Antimicrobial therapy
Antimicrobial therapy primary affects inflammatory lesions.
Oral and topical antibiotics should not usually be used as monotherapy.
Antibiotics are generally well tolerated, but are associated with rare instances of severe adverse events (minocycline).
Antibiotics should be combined with topical retinoids to enhance efficacy against comedones and inflammatory acne lesions.
Benzoyl peroxide alone significantly improves inflammatory acne.
Topical benzoyl peroxide or azaleic acid treatment may be added to antibiotics to reduce the potential of developing P acnesresistance.
Hormonal therapy
Excellent choice for women who need oral contraception for gynaecologic reasons.
Use early in female patients with moderate to severe acne or with seborrhea/acne/hirsutism/alopecia (SAHA) symptoms.
Useful as a component of combination therapy in women with or without endocrine abnormalities.
Sometimes used in women with late-onset acne.
Oral retinoids
Oral isotretinoin is the mainstay of therapy for severe acne.
Targets all pathophysiologic factors in acne.
May achieve dramatic results even in severe disease.
Now used more frequently in moderate, nonresponsive acne.
Side-effects are common, but usually manageable.
Education is vital (side-effects, teratogenicity, adverse psychiatric events, monitoring).
Variable rate of recurrence; retreatment may be necessary.
(Ref: Cunliffe WJ and Gollnick H, H. Management of acne. A report from a global alliance to improve outcomes in acne. Am Acad Dermatol 2003; 49 (1): S1-S37)
Key consensus recommendations:
Acne pathophysiology should influence treatment, which should target as many factors as possible.
Retinoids
Most patients with acne benefit from a retinoid – with a topical agent as part of conventional therapy, or oral isotretinoin for treatment-resistant cases.
Topical retinoids have multiple anti-acne actions, and should be primary treatment for most forms of acne vulgaris.
Use early for best results.
Should be applied to the entire affected area.
Combine with antimicrobial therapy when inflammatory lesions are present.
Essential part of maintenance therapy.
Antimicrobials plus topical retinoid therapy
Antimicrobial therapy plus topical retinoid therapy is significantly better than antimicrobials alone.
Combination therapy allows targeting of different pathophysiologic factors.
Topical retinoid therapy is likely to enhance penetration of antimicrobial agents.
Add topical retinoids early—at the onset of therapy—for greatest and fastest results.
Maintain success by continuing with topical retinoid.
Combination therapy
Should be used when inflammatory lesions are present.
Speeds clearing and provides greater resolution of both inflammatory lesions and comedones
Topical retinoid should be started at the initiation of antimicrobial therapy
Antibiotic should be discontinued when inflammatory lesions resolve adequately.
If this is not possible, then switch to a combination agent with benzoyl peroxide plus an antibiotic.
Continue use of topical retinoid to maintain remission of new acne lesions when antibiotic therapy is discontinued.
Antimicrobial therapy
Antimicrobial therapy primary affects inflammatory lesions.
Oral and topical antibiotics should not usually be used as monotherapy.
Antibiotics are generally well tolerated, but are associated with rare instances of severe adverse events (minocycline).
Antibiotics should be combined with topical retinoids to enhance efficacy against comedones and inflammatory acne lesions.
Benzoyl peroxide alone significantly improves inflammatory acne.
Topical benzoyl peroxide or azaleic acid treatment may be added to antibiotics to reduce the potential of developing P acnesresistance.
Hormonal therapy
Excellent choice for women who need oral contraception for gynaecologic reasons.
Use early in female patients with moderate to severe acne or with seborrhea/acne/hirsutism/alopecia (SAHA) symptoms.
Useful as a component of combination therapy in women with or without endocrine abnormalities.
Sometimes used in women with late-onset acne.
Oral retinoids
Oral isotretinoin is the mainstay of therapy for severe acne.
Targets all pathophysiologic factors in acne.
May achieve dramatic results even in severe disease.
Now used more frequently in moderate, nonresponsive acne.
Side-effects are common, but usually manageable.
Education is vital (side-effects, teratogenicity, adverse psychiatric events, monitoring).
Variable rate of recurrence; retreatment may be necessary.
(Ref: Cunliffe WJ and Gollnick H, H. Management of acne. A report from a global alliance to improve outcomes in acne. Am Acad Dermatol 2003; 49 (1): S1-S37)






0 comments:
Post a Comment